Exelixis, Inc.
(EXEL - NASDAQ)
45,05 USD
📋 Profilo Aziendale

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States.

|